MSC Advertisement

Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Antengene Announces First Patient Dosed in Phase II Trial of ATG-008 (Onatasertib) in Patients with Advanced Solid Tumors with Specific Genetic Alterations

Monday, April 12, 2021

Antengene Corporation Limited a leading innovative biopharmaceutical company dedicated to discovering developing and commercializing global firstinclass andor bestinclass therapeutics in hematology and oncology

HEC Pharm Selects ABEC Large-Scale Fermenters to Increase Biopharmaceutical Production Capacity

Monday, April 12, 2021

ABEC a global provider of integrated solutions and services for biopharmaceutical manufacturing announced it will design manufacture and install multiple L fermenter trains for HEC Pharms manufacturing site in Guangzhou China

Celcuity Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Gedatolisib, a First-in-Class PI3K/mTOR Inhibitor for Breast Cancer

Friday, April 09, 2021

Celcuity Inc a clinicalstage biotechnology company pursuing an integrated companion diagnostic and therapeutic strategy for treating patients with cancer today announced it has entered into a global licensing agreement with Pfizer Incgranting Celcuit...

Context Therapeutics and Integral Molecular Enter Collaboration and License Deal for Novel Claudin 6 Antibodies for Gynecologic Cancer Therapeutic Program

Friday, April 09, 2021

Context Therapeutics a clinicalstage womens oncology company developing advanced small molecule and immunotherapy treatments to transform care for hormonedriven breast and gynecological cancers

Shanghai Genechem Co., Ltd. (Genechem) announces global collaboration on bispecific antibodies

Thursday, April 08, 2021

Shanghai Genechem Co Ltd Genechem a discovery company dedicated to the discovery of new drug targets and the development of new therapeutic products today announced the conclusion of a global collaboration with IMab

Progenity and Ionis Pharmaceuticals Enter into Agreement to Evaluate Progenity’s Ingestible Oral Biotherapeutics Technology for Delivery of Antisense Therapies

Thursday, April 08, 2021

Progenity Inc a biotechnology company with an established track record of success developing and commercializing molecular testing products today announced an agreement with Ionis Pharmaceuticals the leader in RNAtargeted therapeutics to evaluate the...

Hadassah and MyBiotics to Collaborate for the Discovery of Microbiome-Based Therapy for Improving Cancer Immunotherapy

Thursday, April 08, 2021

MyBiotics Pharma Ltd a microbiome therapeutics company and Hadasit Medical Research Services and Development Ltd the technology transfer office of Hadassah Medical Center announced that they have entered into a research collaboration and licensing ag...

Cidara Therapeutics Announces Agreement with Janssen to Develop and Commercialize AVCs for the Prevention and Treatment of Influenza

Tuesday, April 06, 2021

Cidara Therapeutics Inc a biotechnology company developing longacting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections announced that it has entered into an exclusive worldwide license and...

Sorrento Enters Into Merger Agreement to Acquire Late-Stage Oncology Company ACEA Therapeutics

Tuesday, April 06, 2021

Sorrento Therapeutics Incannounced the signing of a merger agreement pursuant to which Sorrento will acquire ACEA Therapeutics Inc ACEA The acquisition will include late clinical stage drug Abivertinib clinical stage candidate AC preclinical stage ca...

Supernus Announces FDA Approval of Qelbree™ (SPN-812) for the Treatment of ADHD

Saturday, April 03, 2021

Supernus Pharmaceuticals Inc a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system CNS diseases today announced that the US Food and Drug Administration FDA approved Qelbree viloxaz...

Latest Issue
Get instant
access to our latest e-book
Rousselot - X-Pure® GelMA Foxx Life Sciences - Bioprocess Meco - 90 years Medical Fair Thailand 2021